[go: up one dir, main page]

US3666800A - Substituted triiodoisophthalamic acids - Google Patents

Substituted triiodoisophthalamic acids Download PDF

Info

Publication number
US3666800A
US3666800A US47886A US3666800DA US3666800A US 3666800 A US3666800 A US 3666800A US 47886 A US47886 A US 47886A US 3666800D A US3666800D A US 3666800DA US 3666800 A US3666800 A US 3666800A
Authority
US
United States
Prior art keywords
acid
triiodo
methylisophthalamic
ethyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US47886A
Inventor
Jack Bernstein
Kathryn Alice Losee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of US3666800A publication Critical patent/US3666800A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Definitions

  • the present invention relates to new compounds of the formula and to basic salts of these compounds, e.g., alkali metal salts such as, for example, sodium and potassium; alkaline earth salts such as, for example, calcium; ammonium salts such as, for example, N-methylglucamine, as well as lower aliphatic esters of up to 6 carbon atoms such as methyl, ethyl, propyl, ipropyl, n-butyl, i-butyl, n-pentyl, 2-methylbutyl, neopentyl, nhexyl, 2-methylpentyl, 3-methylpentyl, 2,2-dimethylbutyl and 2 ,3-dimethylbutyl esters.
  • the R and R. are hydrogen or an alkyl radical of up to six carbon atoms and R is an alkyl radical of up to six carbon atoms.
  • the new compounds of the present invention include the following compounds as well as the above-mentioned basic salts and aliphatic esters thereof:
  • the reaction is carried out in an inert solvent such as ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, dimethylformarnide, dimethylacetamide, tetrahydrofuran, dimethylsulfoxide and the like.
  • an inert solvent such as ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, dimethylformarnide, dimethylacetamide, tetrahydrofuran, dimethylsulfoxide and the like.
  • a hydrogen chloride acceptor such as pyridine, N-methylmorpholine, triethyl-amine, etc., in which case the hydrogen chloride acceptor may also be used as the solvent, if desired.
  • the starting materials of formula II in which R is hydrogen are readily obtained by the procedure described by Hoey et al. [1. Med. Chem. 6, 24 (1963)].
  • the starting materials of formula II in which R is alkyl are obtained by condensing 5- arnino N-substituted-isophthalamic acids with an aldehyde, followed by reduction of the Schiff base thus obtained to the 5-alkylamino-N-substituted-isophthalamic acid.
  • the acids are reacted with an inorganic or organic base, e.g., alkali metal hydroxide such as sodium hydroxide, or amines, such as nmethylglucamine.
  • an inorganic or organic base e.g., alkali metal hydroxide such as sodium hydroxide, or amines, such as nmethylglucamine.
  • the esters may be formed by treating an alkaline solution of a compound offormula l with a di(lower alkyl) sulfate such as dimethyl sulfate or by treatment with a diazoalkane such as diazomethane.
  • the salts, especially insoluble salts frequently provide a convenient means of isolating and purifying the product.
  • the new products of fonnula l are useful as radiopaque agents for visualization of animal systems or organs, preferably in the fom'l of physiologically acceptable salts such as sodium or methylglucamine salts for the preparation of solutions for intravascular injection for urography and for vasographic techniques such as angiocardiography, arteriography, nephrography and venography.
  • physiologically acceptable salts such as sodium or methylglucamine salts
  • the water-insoluble esters are useful in visualizing hollow organs and cavities having external orifices through which'the contrast preparation can be introduced in preparation for the examination and removal after the examination is completed.
  • the precipitated solid is filtered, washed with dilute hydrochloric acid and dried under reduced pressure at about 100.
  • The; 5- (3-methylureido)-2,4,6-triiodo-N-methylisophthalamic acid thus obtained is a white solid melting at about l-l85 with decomposition.
  • EXAMPLE 4 S-( 3-Methylureido )-2,4,6-Triiodo-N-Ethylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of -5 -amino-2,4,6-triiodo-N-ethylisophthalamic acid for the 5-amino-2,4,6-triiodoN-methylisophthalamic acid, there is obtained the desired 5-(3- methylureido)-2,4,6-triiodo-N-ethylisophthalamic acid.
  • EXAMPLE 6 5-( S-Ethylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid a. Methyl N-Ethyl-N-Methyl-S-Nitroisophthalamate A solution of 55.6 grams of 3-carbomethoxy-5-nitrobenzoyl chloride in 200 ml of carbon tetrachloride is added slowly to a well-stirred mixture of 13.5 grams of ethylmethylamine, 200 ml of water, 50 ml of acetone and 9.3 grams of sodium hydroxide. The carbon tetrachloride and acetone are removed by concentration under reduced pressure.
  • the precipitated solid is filtered, washed with water and redissolved in dilute aqueous ammonia.
  • the solution is treated with decolorizing carbon, filtered and acidified with dilute hydrochloric acid.
  • the precipitate is collected by filtration, washed with water and then recrystallized from aqueous alcohol to yield the desired N-ethyl-N-methyl-S- nitroisophthalamic acid.
  • 5-Amino-N-Ethyl-N-Methylisophthalamic Acid A mixture of 12 grams of N-ethyl-N-methyl-S- nitroisophthalamic acid, 1 gram of 5 percent palladium on carbon and l50 ml of methanol is shaken in a Parr hydrogenator under a pressure of 50 lbs/sq.in. of hydrogen. After the theoretical quantity of hydrogen has been absorbed, the mixture is filtered and the catalyst washed thoroughly with methanol. The filtrate and washings are combined and concentrated under reduced pressure to yield the desired 5- amino-N-ethyl-N-methylisophthalamic acid. d.
  • EXAMPLE 7 5-( 3 ,3-Dimethylureido )-2,4,6-Triiodo-N- Methylisophthalamic Acid To 3 grams of 5-amino-2,4,6triiodoN-methylisophthalamic acid in 25 ml of anhydrous pyridine there is added dropwise, with vigorous stirring, a solution of 1 gram of dimethylcarbamoyl chloride in l0 ml of anhydrous benzene. The reaction mixture is warmed gently to complete the reaction and then concentrated under reduced pressure to remove the benzene. The residue is poured onto a mixture of ice and 20 percent hydrochloric acid.
  • the precipitated solid is filtered, washed with dilute acid, and dried at 100 under reduced pressure to yield the desired 5-(3,3-dirnethyl-ureido)-2,4,6-trii0do-N- methylisophthalamic acid.
  • the product may be purified by solution in dilute alkali and reprecipitation with hydrochloric acid.
  • EXAMPLE 8 5-( 3-Methyll -n-Propylureido )2,4,6-Triiodo-N- Methylisophthalamic Acid a) 5-nPropylamino-N-Methylisophthalamic Acid To a solution of 9.7 grams of S-amino-N- methylisophthalamic acid in 150 ml of methanol, there is added 4 ml of propionaldehyde and the mixture hydrogenated at room temperature and atmospheric pressure using 4 grams of Raney nickel as catalyst. The catalyst is filtered off, and the filtrate concentrated under reduced pressure to yield the desired 5-n-propylamino-N-methylisophthalamic acid. b.
  • EXANIPLE 9 5-( 3 ,B-Dimethyll-n-Propylureido )-2,4,6-Triiodo-N-Methyllsophthalarnic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-n-propylamino-2,4,6-triiodo-N- methylisophthalamic acid for the 5-amino-2,4,6-triiodo-N- methylisophthalamic acid, there is obtained the desired 5- EXAMPLE l 3-Methyll -n-Propylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid a) 5-n-Propylamino-2,4,6Triiodo-N-Ethyl-N- Methylisophthalarnic Acid Following the procedure of Example 8 a,b, but substituting an equivalent amount of S-arnino-N-ethyl
  • EXAMPLE 14 a 5-Ethylamino-2,4,6-Triiodoisophtha1amic Acid Following the procedure of Example 8 a,b, but substituting an equivalent amount of S-aminoisophthalamic acid for the 5- amino-N-methylisophthalamic acid and an equivalent amount EXAMPLE l5 5-( l,3,3-Triethylureido)-2,4,6-Triiodoisophthalamic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-ethylamino-2,4,6-triiodoisophthalamic acid for the 5-amino-2,4,6-triiodo-N-methyl-isophthalamic acid and an ealuivalent amount of dieth 'l-carbamoyl chloride ere is obtained the for the dime ylcarbamoyl chloride, desired 5-( l,3,3-triethylureido)-2,4,6-triiodoiso
  • EXAMPLE l6 Ethyl 5-( 3-methylureido)-2,4,6-Triiodo-N-Methylisophthalamate To a stirred slurry of 21 grams of 5-( 3-methyl-ureido)-2,4,6 -triiodo-N-methylisophthalamic acid in ml of absolute ethanol, there is added a solution of '2.2 grams of potassium hydroxide in 50 m] of absolute ethanol. To this mixture there is added 4.5 ml of diethyl sulfate. The mixture is allowed to stir overnight and I00 ml of water added. The reaction mixture is concentrated to dryness and suspended in dilute alkali.
  • the solution is filtered and the crude ester thus obtained is the desired ethyl 5-( 3-methylureido)-2,4,6-triiodo-N- methylisophthalamate.
  • the product may be purified by solution in warm dimethylformamide, treating with decolorizing carbon and dilution of the filtrate with water to precipitate the desired ester.
  • R and R are hydrogen or alkyl of up to six carbon atoms and R is alkyl of up to six carbon atoms, as well as lower alkyl esters and physiologically acceptable salts thereof wherein the alkyl ester has up to six carbon atoms.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

WHEREIN R and R2 are hydrogen or alkyl and R'' is alkyl, as well as salts and lower alkyl esters of these compounds are useful as radiopaque agents.

Compounds having the formula

Description

United States Patent Bernstein et a].
[4 1 May 30, 1972 SUBSTITUTED TRIIODOISOPHTHALAMIC ACIDS [72] Inventors: Jack Bernstein; Kathryn Alice Losee, both of New Brunswick, NJ.
[73] Assignee: E. R. Squibb 8: Sons, Inc., New York,
[22] Filed: June 19, 1970 [2]] Appl. No.: 47,886
Fieser, L. F., et a]. Organic Chemistry, 3rd Edit. (1956), pub. by Reinhold Pub. Corp. page. 608 cited.
Primary Examiner-Lorraine A. Weinberger Assistant Examiner-L. Arnold Thaxton Attorney-Lawrence S. Levinson, Merle J. Smith, Donald J. Perrella and Burton Rodney ABSTRACT Compounds having the formula wherein R and R are hydrogen or alkyl and R is alkyl, as well as salts and lower alkyl esters of these compounds are useful as radiopaque agents.
5 Claims, No Drawings OBJECTS OF THE INVENTION It is an object of the present invention to provide new compounds which are useful radiopaque agents. Another object is to provide methods for the preparation of these compounds. These and other objects of the present invention will be ap parent from the following description.
DETAILED DESCRIPTION The present invention relates to new compounds of the formula and to basic salts of these compounds, e.g., alkali metal salts such as, for example, sodium and potassium; alkaline earth salts such as, for example, calcium; ammonium salts such as, for example, N-methylglucamine, as well as lower aliphatic esters of up to 6 carbon atoms such as methyl, ethyl, propyl, ipropyl, n-butyl, i-butyl, n-pentyl, 2-methylbutyl, neopentyl, nhexyl, 2-methylpentyl, 3-methylpentyl, 2,2-dimethylbutyl and 2 ,3-dimethylbutyl esters. In the compounds of the present invention the R and R. are hydrogen or an alkyl radical of up to six carbon atoms and R is an alkyl radical of up to six carbon atoms.
The new compounds of the present invention include the following compounds as well as the above-mentioned basic salts and aliphatic esters thereof:
5-( 3-methylureido )-2,4,o-triiodo-N-methyl-isophthalamic acid 5-(3-n-butylureido)-2,4,6-triiodo-N-methyl-isophthalamic acid 5-( 3-n-hexylureido )-2,4,6-triiodo-N-methyl-isophthalamic acid 5-( 3-methylureido)-2,4,6-triiodo-N-ethyl-isophthalamic acid 5-( 3-methylureido )-2,4,6-triiodo-N,N-dimethylisophthalamic acid 5-( 3-ethylureido )-2,4,6-triiodoN-ethyl-N- methylisophthalamic acid 5-( 3 ,3dimethylureido )-2 ,4 ,6-triiodo-N-methylisophthalamic acid 5-( 3-methyll -n-propylureido)-2,4,6-triiodo-N- methylisophthalamic acid 5-( 3,3-dimethyll -n-propylureido )-2,4,6-triiodo-N- methylisophthalamic acid 5-( 3-methyll -n-propylureido)-2,4,6-triiodo-N-ethyl-N- methylisophthalamic acid 5-( 3,3-dimethyll -n-propylureido )-2,4,6-triiodo-N-ethyl-N- methylisophthalamic acid 5-( 3-n-butylureido)-2,4,6-triiodoisophthalamic acid 5-( 3,3-dimethylureido)-2,4,6-triiodoisophthalamic acid 5-( 3-methyll -ethylureido)-2,4,6-triiodoisophthalamic acid 5-( l,3,3-triethylureido)-2,4,6-triiodoisophthalamic acid The compounds of the present invention may be prepared by the reaction of an appropriately substituted 5-amino-2,4,6- triiodoisophthalamic acid of the formula II 30 OH N m R wherein R and R are as previously defined with an alkyl isocyanate of the formula R'NCO ill or a dialkylcarbamoyl halide of the formula Iv R N-C O-X a- H Rf wherein X is a halogen, preferably chlorine and R is as previously defined.
The reaction is carried out in an inert solvent such as ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, dimethylformarnide, dimethylacetamide, tetrahydrofuran, dimethylsulfoxide and the like. In those cases where a dialkylcarbamoyl chloride is a reactant, it is advantageous to use a hydrogen chloride acceptor, such as pyridine, N-methylmorpholine, triethyl-amine, etc., in which case the hydrogen chloride acceptor may also be used as the solvent, if desired.
The starting materials of formula II in which R is hydrogen are readily obtained by the procedure described by Hoey et al. [1. Med. Chem. 6, 24 (1963)]. The starting materials of formula II in which R is alkyl are obtained by condensing 5- arnino N-substituted-isophthalamic acids with an aldehyde, followed by reduction of the Schiff base thus obtained to the 5-alkylamino-N-substituted-isophthalamic acid.
To prepare salts of the compound .of formula I, the acids are reacted with an inorganic or organic base, e.g., alkali metal hydroxide such as sodium hydroxide, or amines, such as nmethylglucamine. The esters may be formed by treating an alkaline solution of a compound offormula l with a di(lower alkyl) sulfate such as dimethyl sulfate or by treatment with a diazoalkane such as diazomethane. The salts, especially insoluble salts, frequently provide a convenient means of isolating and purifying the product.
The new products of fonnula l are useful as radiopaque agents for visualization of animal systems or organs, preferably in the fom'l of physiologically acceptable salts such as sodium or methylglucamine salts for the preparation of solutions for intravascular injection for urography and for vasographic techniques such as angiocardiography, arteriography, nephrography and venography. The water-insoluble esters are useful in visualizing hollow organs and cavities having external orifices through which'the contrast preparation can be introduced in preparation for the examination and removal after the examination is completed. Solutions having EXAMPLE l 5-( 3Methylureido)-2,4,6-Triiodo-N-Methylisophthalamic Acid To a solution of 1 gram of 5-amino-2,4,6-triiodo-N- methylisophthalamic acid in 100 ml of ethylene glycol dimethyl ether there is added lml of methyl isocyanate and the reaction mixture heated under reflux for 20 hours. The solvent is removed by distillation under reduced pressure and the residue dissolved in dilute sodium hydroxide solution. The solution is treated with decolorizing carbon, filtered and made strongly acid with 10 percent hydrochloric acid. The precipitated solid is filtered, washed with dilute hydrochloric acid and dried under reduced pressure at about 100. The; 5- (3-methylureido)-2,4,6-triiodo-N-methylisophthalamic acid thus obtained is a white solid melting at about l-l85 with decomposition.
EXAMPLE 2 5-(3-n-Butylureido)-2,4,6-Triiodo-N-Methylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of n-butyl' isocyanate for the methyl iso-.
cyanate, there is obtained the desired S-(S-n-butyl-ureido 2,4,fi-triiodo-N-methylisophthalamic acid.
EXAMPLE 3 3-N-Hexylureido )-2 ,4,6-Triiodo-N-Methylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of n-hexyl isocyanate for the methyl isocyanate, there is obtained the desired 5-( 3-n-hexyl-ureido)- 2,4,6-triiodo-N-methylisophthalamic acid.
EXAMPLE 4 S-( 3-Methylureido )-2,4,6-Triiodo-N-Ethylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of -5 -amino-2,4,6-triiodo-N-ethylisophthalamic acid for the 5-amino-2,4,6-triiodoN-methylisophthalamic acid, there is obtained the desired 5-(3- methylureido)-2,4,6-triiodo-N-ethylisophthalamic acid.
EXAMPLE 5 5-(3-Methylureido)-2,4,6-Triiodo-N,N-Dimethylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of S-amino-2,4,6-triiodo-N,N-dimethylisophthalamic acid for the 5-amino-2,4,6 triiodo-N-methylisophthalamic acid, there is obtained the desired 5-(3- methylureido )-2,4,6-triiodo-N,N-dimethylisophthalamic acid.
EXAMPLE 6 5-( S-Ethylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid a. Methyl N-Ethyl-N-Methyl-S-Nitroisophthalamate A solution of 55.6 grams of 3-carbomethoxy-5-nitrobenzoyl chloride in 200 ml of carbon tetrachloride is added slowly to a well-stirred mixture of 13.5 grams of ethylmethylamine, 200 ml of water, 50 ml of acetone and 9.3 grams of sodium hydroxide. The carbon tetrachloride and acetone are removed by concentration under reduced pressure. The residue is cooled and the precipitated methyl N-ethyl-N- methyl-5-nitroisophthalamate separated from the aqueous layer. b. N-Ethyl-N-Methyl-S-Nitroisophthalamic Acid The crude methyl N'ethyl-N-methyl-5-nitroisophthalamate obtained in (a) is dissolved in a minimum amount of alcohol and an equal volume of water is added. Sodium carbonate is added until the pH of the mixture is 8 and the reaction mixture is then heated to reflux with stirring for 1 hour. The mixture is diluted with water, filtered and the filtrate poured into excess hydrochloric acid. The precipitated solid is filtered, washed with water and redissolved in dilute aqueous ammonia. The solution is treated with decolorizing carbon, filtered and acidified with dilute hydrochloric acid. The precipitate is collected by filtration, washed with water and then recrystallized from aqueous alcohol to yield the desired N-ethyl-N-methyl-S- nitroisophthalamic acid. c. 5-Amino-N-Ethyl-N-Methylisophthalamic Acid A mixture of 12 grams of N-ethyl-N-methyl-S- nitroisophthalamic acid, 1 gram of 5 percent palladium on carbon and l50 ml of methanol is shaken in a Parr hydrogenator under a pressure of 50 lbs/sq.in. of hydrogen. After the theoretical quantity of hydrogen has been absorbed, the mixture is filtered and the catalyst washed thoroughly with methanol. The filtrate and washings are combined and concentrated under reduced pressure to yield the desired 5- amino-N-ethyl-N-methylisophthalamic acid. d. 5-Amino-2,4,6-Triiodo-N-Ethyl-N-Methylisophthalamic Acid To a stirred suspension of grams of S-amino-N-ethyl-N- methylisophthalamic acid in 250 ml of water there is added over the course of 1 hour a solution of l6 grams of iodine monochloride and 19 grams of potassium chloride in 150 ml of water. The reaction mixture is stirred for 5 hours after the addition is complete and a solution of 10 grams of sodium hydroxide in 25 ml of water added. To this stirred mixture there is then added a solution of 8 grams of iodine monochloride and 9.5 grams of potassium chloride in 75 ml of water over the course of 1 hour. The 'reaction mixture is stirred for 24 hours and the 5-amino-2,4,6-triiodoN-ethyl-N- methylisophthalarnic acid filtered and washed thoroughly with water. The product may be purified by crystallization of the ammonium salt and conversion of the ammonium salt to the free acid by treatment with hydrochloric acid. e. 5-( 3-Ethylureido )-2,4,6Triiodo-N-Ethyl-N-Methyllsophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of ethyl isocyanate for the methyl isocyanate and an equivalent amount of 5-amino-2,4,6-triiodo- N-ethyl-N-methylisophthalamic acid for the 5-amino-2,4,6- triiodo-N-methylisophthalamic acid, there is obtained the desired 5-( 3-ethylureido )-2,4,6-triiodo-N-ethyl-N- methylisophthalamic acid.
EXAMPLE 7 5-( 3 ,3-Dimethylureido )-2,4,6-Triiodo-N- Methylisophthalamic Acid To 3 grams of 5-amino-2,4,6triiodoN-methylisophthalamic acid in 25 ml of anhydrous pyridine there is added dropwise, with vigorous stirring, a solution of 1 gram of dimethylcarbamoyl chloride in l0 ml of anhydrous benzene. The reaction mixture is warmed gently to complete the reaction and then concentrated under reduced pressure to remove the benzene. The residue is poured onto a mixture of ice and 20 percent hydrochloric acid. The precipitated solid is filtered, washed with dilute acid, and dried at 100 under reduced pressure to yield the desired 5-(3,3-dirnethyl-ureido)-2,4,6-trii0do-N- methylisophthalamic acid. The product may be purified by solution in dilute alkali and reprecipitation with hydrochloric acid.
EXAMPLE 8 5-( 3-Methyll -n-Propylureido )2,4,6-Triiodo-N- Methylisophthalamic Acid a) 5-nPropylamino-N-Methylisophthalamic Acid To a solution of 9.7 grams of S-amino-N- methylisophthalamic acid in 150 ml of methanol, there is added 4 ml of propionaldehyde and the mixture hydrogenated at room temperature and atmospheric pressure using 4 grams of Raney nickel as catalyst. The catalyst is filtered off, and the filtrate concentrated under reduced pressure to yield the desired 5-n-propylamino-N-methylisophthalamic acid. b. 5-n-Propylamino-2,4,6-Triiodo-N-Methylisophthalamic Acid Following the procedure of Example 6d but substituting an equivalent amount of S-n-propylamino-N-methylisophtha]amic acid for the 5-amino-N-ethyl-N-methylisophthalamic acid, there is obtained the desired 5-n-propylamino2,4,6Triiodo- N-methylisophthalamic acid.
EXANIPLE 9 5-( 3 ,B-Dimethyll-n-Propylureido )-2,4,6-Triiodo-N-Methyllsophthalarnic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-n-propylamino-2,4,6-triiodo-N- methylisophthalamic acid for the 5-amino-2,4,6-triiodo-N- methylisophthalamic acid, there is obtained the desired 5- EXAMPLE l 3-Methyll -n-Propylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid a) 5-n-Propylamino-2,4,6Triiodo-N-Ethyl-N- Methylisophthalarnic Acid Following the procedure of Example 8 a,b, but substituting an equivalent amount of S-arnino-N-ethyl-N- methylisophthalamic acid for the S-amino-N- methylisophthalamic acid, there is obtained the desired 5-npropylamino-2,4,6-triiodo-N-ethyl-N-methylisophthalamic acid. b. 5-( 3-Methyl-1-n-Pr0pylureido)-2,4,6-Tiiiodo-N-Ethyl-N- Methylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of 5-n-propylamino-2,4,6-triiodo-N-ethyl- N-methylisophthalamic acid for the 5-amino-2,4,6-triiodo-N- methylisophthalamic acid, there is obtained the desired 5-( 3- methyl- 1 n-propylureido )-2.4,6-triiodo-N-ethyl-N- methylisophthalamic acid.
EXAMPLE 1 l 5-( 3 ,3-Dimethyll -n-Propylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid Following the procedure of Example 7 but substituting an equivalent amount of S-n-propylureido-2,4,6-triiodo-N-ethyl- N-methylisophthalamic acid for the 5-amino-2,4,6-triiodo-N- methylisophthalamic acid, there is obtained the desired 5- (3,3-dimethyll n-propylureido )-2,4,6triiodo-N-ethyl-N- methylisophthalamic acid.
EXAMPLE l2 5-( 3-n-Butylureido)-2,4,6-Triiodoisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount 'of 5-amino-2,4,6-triiodoisophthalamic acid for the 5-amino-2,4,6-triiodo-N-methylisophthalamic acid and an equivalent amount of n-butyl isocyanate for the methyl isocyanate, there is obtained the desired 5-( B-n-butylureido)-2,4,6-triiodoisophthalamic acid.
EXAMPLE l3 5( 3 ,3-Dimethylureido)-2,4,6-Triiodoisophthalamic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-amino-2,4,6-triiodoisophthalamic acid for the 5-amino-2,4,6-triiodo-N-methylisophthalamic acid there is obtained the desired 5-(3,3-dimethylureido)- 2,4,6-triiodoisophthalamic acid.
EXAMPLE 14 a. 5-Ethylamino-2,4,6-Triiodoisophtha1amic Acid Following the procedure of Example 8 a,b, but substituting an equivalent amount of S-aminoisophthalamic acid for the 5- amino-N-methylisophthalamic acid and an equivalent amount EXAMPLE l5 5-( l,3,3-Triethylureido)-2,4,6-Triiodoisophthalamic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-ethylamino-2,4,6-triiodoisophthalamic acid for the 5-amino-2,4,6-triiodo-N-methyl-isophthalamic acid and an ealuivalent amount of dieth 'l-carbamoyl chloride ere is obtained the for the dime ylcarbamoyl chloride, desired 5-( l,3,3-triethylureido)-2,4,6-triiodoisophthalamic acid.
EXAMPLE l6 Ethyl 5-( 3-methylureido)-2,4,6-Triiodo-N-Methylisophthalamate To a stirred slurry of 21 grams of 5-( 3-methyl-ureido)-2,4,6 -triiodo-N-methylisophthalamic acid in ml of absolute ethanol, there is added a solution of '2.2 grams of potassium hydroxide in 50 m] of absolute ethanol. To this mixture there is added 4.5 ml of diethyl sulfate. The mixture is allowed to stir overnight and I00 ml of water added. The reaction mixture is concentrated to dryness and suspended in dilute alkali. The solution is filtered and the crude ester thus obtained is the desired ethyl 5-( 3-methylureido)-2,4,6-triiodo-N- methylisophthalamate. The product may be purified by solution in warm dimethylformamide, treating with decolorizing carbon and dilution of the filtrate with water to precipitate the desired ester.
What is claimed is:
l. A compound of the formula wherein R and R are hydrogen or alkyl of up to six carbon atoms and R is alkyl of up to six carbon atoms, as well as lower alkyl esters and physiologically acceptable salts thereof wherein the alkyl ester has up to six carbon atoms.
2. A compound of claim 1 wherein R and R are hydrogen.
3. A compound of claim 1 wherein R and R are alkyl.
4. A compound of claim 1 wherein R is hydrogen and R is alkyl.
5. A compound of claim 1 wherein R is alkyl and R is hydrogen.

Claims (4)

  1. 2. A compound of claim 1 wherein R and R2 are hydrogen.
  2. 3. A compound of claim 1 wherein R and R2 are alkyl.
  3. 4. A compound of claim 1 wherein R2 is hydrogen and R is alkyl.
  4. 5. A compound of claim 1 wherein R2 is alkyl and R is hydrogen.
US47886A 1970-06-19 1970-06-19 Substituted triiodoisophthalamic acids Expired - Lifetime US3666800A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4788670A 1970-06-19 1970-06-19

Publications (1)

Publication Number Publication Date
US3666800A true US3666800A (en) 1972-05-30

Family

ID=21951563

Family Applications (1)

Application Number Title Priority Date Filing Date
US47886A Expired - Lifetime US3666800A (en) 1970-06-19 1970-06-19 Substituted triiodoisophthalamic acids

Country Status (4)

Country Link
US (1) US3666800A (en)
DE (1) DE2129887A1 (en)
FR (1) FR2100792A1 (en)
HU (1) HU163043B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914294A (en) * 1972-06-01 1975-10-21 Squibb & Sons Inc 3,5-Disubstituted-2,4,6-triiodobenzoic acids
US3953497A (en) * 1974-07-29 1976-04-27 Mallinckrodt, Inc. 2,4,6-Triiodo-5-methoxyacetamido-N-methylisophthalamic acid and salts, acyl halides and esters thereof
US4018783A (en) * 1970-09-09 1977-04-19 Beecham Group Limited Esters of metrizoic acid

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454507A1 (en) 2001-12-15 2004-09-08 Hermsdorfer Institut für Technische Keramik e.V. Electrical resistance heating element with a honeycomb body

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Fieser, L. F., et al. Organic Chemistry, 3rd Edit. (1956), pub. by Reinhold Pub. Corp. page. 608 cited. *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018783A (en) * 1970-09-09 1977-04-19 Beecham Group Limited Esters of metrizoic acid
US3914294A (en) * 1972-06-01 1975-10-21 Squibb & Sons Inc 3,5-Disubstituted-2,4,6-triiodobenzoic acids
US3953497A (en) * 1974-07-29 1976-04-27 Mallinckrodt, Inc. 2,4,6-Triiodo-5-methoxyacetamido-N-methylisophthalamic acid and salts, acyl halides and esters thereof

Also Published As

Publication number Publication date
FR2100792A1 (en) 1972-03-24
HU163043B (en) 1973-05-28
DE2129887A1 (en) 1973-07-12

Similar Documents

Publication Publication Date Title
US3795698A (en) Acetoxy methyl and pivaloyloxymethyl 5-acetamido-2,4,6-triiodo-n-methylisophthalamates
DE2508045A1 (en) SUBSTITUTED N- (1-BENZYLPYRROLIDINYL-2-ALKYL) BENZAMIDES, METHOD FOR THE PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE
Wallingford et al. X-Ray Contrast Media. I. Iodinated Acylaminobenzoic Acids1
US2567651A (en) J-dialkyl-g-amino-l
US3666800A (en) Substituted triiodoisophthalamic acids
US3660464A (en) Tri-iodinated diaminobenzoic acid derivatives
US2680133A (en) Iodine-containing amino-benzoyl derivatives of amino acids
IL23351A (en) Benzenesulphonyl-ureas and process for the manufacture thereof
DE2454107A1 (en) SUBSTITUTED UREA, ACYLURA AND SULFONYLURA DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
DE1287081B (en) Process for the preparation of N, N'-bis- (3-amino-5-carboxy-2, 4, 6-triiodophenyl) -alkanedicarboxamides or the corresponding carbonic acid diamides
US3734953A (en) Tris-triiodoisophthalamic acids and derivatives
CA1339665C (en) Iodinated non-ionic triodobenzene compounds and contrast media containing them
US3210412A (en) m-(alkanamidoalkanamido)-2, 4, 6-triiodobenzoic acid compounds
US3666799A (en) Triiodated toluic acids
US2633466A (en) Anhydro 2-carboxylicacylamino-3, 5-diiodobenzoic acids and process
US3819821A (en) X-ray opacifiers
US3660469A (en) Bis-triiodoisophthalamic acid compounds
US3721701A (en) Radiopaque triiodoalkylureido benzoic acids
US3660466A (en) 2 4 6-triiodobenzoic acid derivatives
US3769406A (en) Treating hyperglycemia with phosphorylated guanidines and biguanidines
US2587936A (en) Iodinated 2-acylamino benzoyl derivatives of amino acids
US2958692A (en) S-carboxymethylmercapto-g-
DE970133C (en) Process for the preparation of N-acyl derivatives of 3, 5-diamino-2, 4, 6-triiodo-benzoic acid
US3359278A (en) Nu-substituted-2, 4, 6-triiodoanilic acids and salts thereof
US2654753A (en) 2-sulfanilamido-5-aminopyrimidine and salts thereof